Population Pharmacokinetic Modeling of Olmesartan, the Active Metabolite of Olmesartan Medoxomil, in Patients with Hypertension

ConclusionThe final population pharmacokinetic model was demonstrated to be appropriate and effective and it can be used to assess the pharmacokinetic parameters of olmesartan in Indian patients with hypertension.

http://link.springer.com/10.1007/s13318-016-0371-0

Source: European Journal of Drug Metabolism and Pharmacokinetics - August 16, 2016 Category: Drugs & Pharmacology Source Type: research